SavedAdd your journal

Journals / Gazi Medical Journal / 2008 / Cilt: 19 - Sayı: 1

Diyabetli Türk çocuklarında insülin pompası kullanımı izlem sonuçları

The follow-up results of insulin pump use in Turkish children with type I diabetes mellitus

Aysun BİDECİ
Peyami CİNAZ
Fatma DEMİREL
Mahmut Orhun ÇAMURDAN
Pages
10–14
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Insulin doses decreased (l.l±0.2 vs. 0.9±0.1 U/kg/day, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Although its use is increasing in children, there are no data about pump use in Turkish children with diabetes.
📊
Key Findings & Data:Materials and Methods: Ten children (age; 14.7±2.6 years, pump therapy duration; 3-24 months) were prospectively studied.
💡
Conclusion & Impact:Insulin doses decreased (l.l±0.2 vs. 0.9±0.1 U/kg/day, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Although its use is increasing in children, there are no data about pump use in Turkish children with diabetes. The aim of this study was to investigate the outcome measures of insulin pump use in diabetic Turkish children. Materials and Methods: Ten children (age; 14.7±2.6 years, pump therapy duration; 3-24 months) were prospectively studied. Main outcome measures were compared with those of the 12 months prior to pump therapy. Results: Although statistically insignificant, HbAlc tended to be lower compared to the pre-pump period. Body mass index Z scores remained similar (0.45±0.76 vs. 0.54±0.53 kg/m2, p>0.05). Insulin doses decreased (l.l±0.2 vs. 0.9±0.1 U/kg/day, p

Özet

Amaç: Çocuklarda kullanımı giderek yaygınlaşmasına rağmen, diyabetli Türk çocuklarında insülin pompası uygulanımma dair yayınlanmış veri yoktur. Bu çalışmanın amacı diyabetli Türk çocuklarında insülin pompası uygulanmanın sonuçlarım araştırmaktır. Gereç ve Yöntemler: Yaş ortalaması 14.7±2.6 yıl, pompa kullanım süresi 3-24 ay olan on diyabetik çocuğun verileri incelenmiş, ve pompa kullanımı öncesi bir senelik sürede elde edilen verilerle karşılaştırılmıştır. Bulgular: İstatistiksel olarak anlamlı olmamakla birlikte, HbAlc düzeyi pompa öncesi döneme kıyasla azalma eğiliminde idi. Vücut kitle indeksi Z skorları benzerdi (Pompa öncesi ve sonrası sırasıyla; 0.45±0.76 ve 0.54±0.53 kg/m2, p>0.05). Ortalama insülin dozu azalmıştı (Pompa öncesi ve sonrası sırasıyla; l.l±0.2 ve 0.9±0.1 U/kg/gün, p

🔖

Cite This Article

BİDECİ, A., CİNAZ, P., DEMİREL, F., ÇAMURDAN, M. O. (2022). Diyabetli Türk çocuklarında insülin pompası kullanımı izlem sonuçları. Gazi Medical Journal, Cilt: 19 - Sayı: 1, 10–14. https://ajindex.com/articles/520333

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. The DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188
  2. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979; 300(11): 573-578
  3. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005; 28:15-19
  4. Cinaz P., Çamurdan M.O., Bideci A., Demirel R, Bakar C. Body mass index values in children with ages 6-16 years. 48th National Pediatrics Congress, Samsun (abstract book) 2004; 421-422
  5. Deiss D, Hartmann R, Hoeffe J, Kordonouri O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabe-. tes2004;5: 117-121
  6. DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004; 145: 380-384
  7. Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics. 2004; 114: e91-95
  8. Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbAlc with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003; 16: 393-399
  9. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 2005; 6: 17-21
  10. Heptulla RA, Allen HF, Gross TM, Reiter EO. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy: Pediatr Diabetes 2004; 5: 10-15
  11. Saha ME, Huuppone T, Mikael K, Juuti M, Komulainen J. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2002; 15: 1005-1010
  12. Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M. Glycemic patterns detected by continuous subcutaneous glucose sen